Edition:
United States

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

143.34USD
8 Dec 2016
Change (% chg)

$1.72 (+1.21%)
Prev Close
$141.62
Open
$140.76
Day's High
$144.18
Day's Low
$140.76
Volume
556,105
Avg. Vol
499,050
52-wk High
$202.18
52-wk Low
$114.54

Summary

Name Age Since Current Position

John Hammergren

57 2002 Chairman of the Board, President, Chief Executive Officer

James Beer

55 2013 Chief Financial Officer, Executive Vice President

Kathleen McElligott

60 2015 Executive Vice President, Chief Technology Officer, Chief Information Officer

Lori Schechter

54 2014 Executive Vice President, Chief Compliance Officer, General Counsel

Jorge Figueredo

55 2008 Executive Vice President - Human Resources

Patrick Blake

52 2009 Executive Vice President, Group President

Paul Julian

60 2004 Executive Vice President, Group President

Bansi Nagji

51 2015 Executive Vice President - Corporate Strategy and Business Development

Edward Mueller

69 2015 Lead Independent Director

Andrew Bryant

66 2008 Independent Director

Wayne Budd

74 2003 Independent Director

N. Anthony Coles

56 2014 Independent Director

M. Christine Jacobs

65 1999 Independent Director

Donald Knauss

65 2014 Independent Director

Marie Knowles

69 2002 Independent Director

Susan Salka

51 2014 Independent Director

Erin Lampert

Vice President - Investor Relations

Biographies

Name Description

John Hammergren

Mr. John H. Hammergren is Chairman of the Board, President and Chief Executive Officer of McKesson Corporation. Mr. Hammergren has served as Chairman of the Board since July 2002, and President and Chief Executive Officer of the Company since April 2001. Mr. Hammergren joined the Company in 1996 and held a number of management positions before becoming President and Chief Executive Officer. He was a director of the Hewlett-Packard Company from 2005 through April 2013. Mr. Hammergren is the Chairman of the Supervisory Board of Celesio AG. Additionally, he is currently a member of the Business Council, the Business Roundtable and the Healthcare Leadership Council, as well as the Board of Trustees for the Center for Strategic & International Studies (“CSIS”). He has been a director of the Company since July 1999. Mr. Hammergren brings more than 30 years of business and healthcare experience to the Board, including service on other public company boards. Under Mr. Hammergren’s leadership, McKesson has become a leading provider of healthcare services and information technology solutions, increased revenues more than $148 billion, expanded global markets and provided shareholders with a significant annual return on investment. The Board benefits from Mr. Hammergren’s extensive knowledge of the Company, including his deep understanding of its customer base, competition, management team, workforce, challenges and opportunities. His involvement with the Healthcare Leadership Council, the Business Council and the Business Roundtable allows him to bring the Board new insights and perspectives on the changing healthcare industry, the nation’s economic and regulatory climate and relevant public policy issues.

James Beer

Mr. James A. Beer is Chief Financial Officer and Executive Vice President of McKesson Corporation, effective October 9, 2013. Prior to joining the Company, Mr. Beer served as Executive Vice President and Chief Financial Officer of Symantec Corporation, from February 2006 to October 2013. Mr. Beer also served as Senior Vice President and Chief Financial Officer of AMR Corporation (“AMR”) and American Airlines, Inc., AMR’s principal subsidiary, from January 2004 to February 2006. From September 1991 to January 2004, Mr. Beer held other management positions in finance and operations at American Airlines, including the airline’s European and Asia Pacific businesses. Beer holds a bachelor’s of science degree in aeronautical engineering from Imperial College, London University and a master’s degree in business administration from Harvard Business School.

Kathleen McElligott

Ms. Kathleen D. McElligott has been promoted as Executive Vice President, Chief Technology Officer, Chief Information Officer of the Company., effective July 20, 2015. As McKesson's CIO, McElligott is responsible for the enterprise business technology strategy, technology governance across the corporation, IT Security and Risk Management, infrastructure operations and service delivery to all McKesson businesses. As CTO, McElligott will guide the overall technology direction for the company's healthcare technology products and provide support and guidance for application development processes companywide. The position serves as a support arm to the management teams within McKesson's technology businesses, working collaboratively with each business to optimize the quality, interoperability, and transparency of McKesson's software development operations. McElligott was hired at Emerson in 2000 as vice president of Information Technology for Emerson Power Transmission. In 2003, she was promoted to vice president of Information Technology for Emerson Industrial Automation, a title she held until her promotion to CIO. Prior to joining Emerson, McElligott spent 22 years with General Electric, holding multiple information systems leadership roles, ultimately becoming CIO of supply chain for GE Aircraft Engines. McElligott received a Bachelor's Degree in Computer Science from Kent State University and a Master's Degree in Business Management from Xavier University

Lori Schechter

Ms. Lori A. Schechter is Executive Vice President, Chief Compliance Officer and General Counsel of McKesson Corporation. Ms. Schechter has served as associate general counsel of McKesson since 2012. Previously, she was a litigation partner at Morrison & Foerster where she represented clients in complex litigation and investigations and served for four years as chair of the 500-lawyer global litigation department. Schechter was named by the National Law Journal as one of the “Top 50 Female Litigators in the Country.” She received her B.A. from Cornell University in 1983, and her J.D. from Yale Law School in 1987.

Jorge Figueredo

Mr. Jorge L. Figueredo is Executive Vice President - Human Resources of McKesson Corporation. He served as Senior Vice President, Human Resources, Dow Jones, Inc. from February 2007 to January 2008. Service with the Company — 5 years.

Patrick Blake

Mr. Patrick J. Blake is Executive Vice President, Group President of McKesson Corporation. He served as President of McKesson Specialty Care Solutions (now McKesson Specialty Health) from April 2006 to June 2009. Service with the Company — 17 years.

Paul Julian

Mr. Paul C. Julian is Executive Vice President, Group President of McKesson Corporation. He served as Senior Vice President from August 1999 to April 2004. Service with the Company – 17 years.

Bansi Nagji

Mr. Bansi Nagji is Executive Vice President - Corporate Strategy and Business Development of McKesson Corporation. Mr. Nagji has more than 20 years of experience working with clients on enterprise-wide growth and innovation challenges in the life sciences and consumer sectors. At Deloitte, he strengthened the company's global reach as the leader of its Global Strategy service line and co-chair of the Global Strategy Governance Committee. A noted expert on innovation, he has authored several articles and papers on the topic. Mr. Nagji has previously served as on the Board of Directors of Deloitte, LLP and several other business and nonprofit boards.

Edward Mueller

Mr. Edward A. Mueller is an Lead Independent Director of McKesson Corporation. Mr. Mueller retired as Chairman and Chief Executive Officer of Qwest Communications International Inc., a provider of voice, data and video services, in April 2011. He held the position of Chairman and Chief Executive Officer of Qwest Communications from August 2007 to April 2011. From January 2003 until July 2006, he served as Chief Executive Officer of Williams-Sonoma, Inc., a provider of specialty products for cooking. Prior to joining Williams-Sonoma, Inc., Mr. Mueller served as President and Chief Executive Officer of Ameritech Corporation, a subsidiary of SBC Communications, Inc., from 2000 to 2002. He was formerly a director of The Clorox Company, CenturyLink, Inc., Williams-Sonoma, Inc. and VeriSign, Inc. Mr. Mueller has been a director of the Company since April 2008 and was elected to the newly created role of Lead Independent Director in July 2013. He was re-elected to a second two-year term as Lead Independent Director in July 2015. He is a member of the Compensation Committee and the Governance Committee. Mr. Mueller brings to the Board chief executive leadership and business management experience, as well as a strong business acumen and strategic planning expertise. Having worked outside the healthcare industry, he also adds to the mix of experiences and perspectives on our Board that promote a robust, deliberative decision-making process. While Chairman of the Board of Qwest Communications, Mr. Mueller had a leadership role in corporate governance, which enables him to provide valuable contributions as a member of the Governance Committee of our Board. He also has public company board experience with audit committee service.

Andrew Bryant

Mr. Andrew D. Bryant is an Independent Director of McKesson Corporation. Mr. Bryant was elected Chairman of the Board of Intel Corporation in May 2012. He was named a director of Intel’s board in July 2011 and served as Vice Chairman of the Board from that time until his election as Chairman. He served as Executive Vice President and Chief Administrative Officer of Intel from October 2007 to July 2011. Mr. Bryant joined Intel in 1981 and held a number of management positions before serving as Intel’s Chief Financial Officer from February 1994 to October 2007. He is also a director of Columbia Sportswear Company. He was formerly a director of Synopsys Inc. Mr. Bryant has been a director of the Company since January 2008. He is Chair of the Compensation Committee and a member of the Finance Committee. Mr. Bryant’s years of experience as an executive at a large global company, including in the roles of Chief Administrative Officer and Chief Financial Officer, provide to the Company’s Board operational, strategic planning and financial expertise and considerable business acumen, as well as international business experience. We believe the Company benefits from his Board leadership perspective garnered from serving as both Vice Chairman and Chairman of Intel’s Board. Mr. Bryant also has other public company board experience with service on audit and governance committees.

Wayne Budd

Mr. Wayne A. Budd is an Independent Director of McKesson Corporation. Mr. Budd joined the law firm of Goodwin Procter LLP as Senior Counsel in October 2004. He had been Senior Executive Vice President and General Counsel and a director of John Hancock Financial Services, Inc. since 2000 and a director of John Hancock Life Insurance Company since 1998. From 1996 to 2000, Mr. Budd was Group President-New England for Bell Atlantic Corporation (now Verizon Communications, Inc.). From 1994 to 1997, Mr. Budd was a Commissioner, United States Sentencing Commission and from 1993 to 1996, he was a senior partner at the law firm of Goodwin Procter LLP. From 1992 to 1993, he was the Associate Attorney General of the United States and from 1989 to 1992, he was United States Attorney for the District of Massachusetts. He is also a director of PBF Energy Inc. Mr. Budd has been a director of the Company since October 2003. He is Chair of the Governance Committee and a member of the Audit Committee. Mr. Budd brings to our Board significant legal and regulatory expertise gained from years of large law firm practice and major governmental positions with law enforcement responsibilities. His legal experience and seasoned judgment have been instrumental in helping the Board navigate legal challenges. In recognition of his distinguished legal career and important contributions to public life, Mr. Budd was named a 2011 recipient of the American Lawyer Lifetime Achievement Award. Additionally, Mr. Budd has senior executive business experience and public company board experience with service on audit, compensation, special litigation and governance committees, including as current chair of the governance committee of PBF Energy Inc. His Board leadership skills have been enhanced through his role as Chairman of the National Board of Directors of the American Automobile Association from April 2011 to April 2013.

N. Anthony Coles

Dr. N. Anthony Coles, Jr., M.D., is an Independent Director of Mckesson Corporation. Dr. Coles was named Chairman and Chief Executive Officer of Yumanity Therapeutics, LLC, a company focused on transforming drug discovery for neurodegenerative diseases, in October 2014. Prior to this, from October 2013, Dr. Coles served as Chairman and CEO of TRATE Enterprises LLC, a privately held company. Dr. Coles served as President, Chief Executive Officer and Chairman of the Board of Onyx Pharmaceuticals, Inc., a biopharmaceutical company (“Onyx”), from 2012 until 2013, having served as its President, Chief Executive Officer and a member of its board of directors from 2008 until 2012. Prior to joining Onyx in 2008, he was President, Chief Executive Officer and a member of the board of directors of NPS Pharmaceuticals, Inc., a public biopharmaceutical company (“NPS”). Before joining NPS in 2005, he served in various leadership positions in the biopharmaceutical and pharmaceutical industries, including at Merck & Co., Inc., Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated. In addition to having previously served as a director of Onyx and NPS, he was formerly a director of Laboratory Corporation of America Holdings and Campus Crest Communities, Inc. Dr. Coles has been a director of the Company since April 2014. He is a member of the Compensation Committee and the Finance Committee. In light of his former and current chairman and chief executive positions, Dr. Coles brings to the Board executive and board leadership experience, as well as business management and strategic planning experience, in the healthcare industry. He also brings an innovative mindset. We believe Dr. Coles’ training as a physician will serve the Board well as it provides oversight with respect to various aspects of the Company’s businesses. In addition, having joined the Board in April 2014, he brings a fresh perspective to the Board and adds to the diversity of perspectives.

M. Christine Jacobs

Ms. M. Christine Jacobs is an Independent Director of McKesson Corporation since January 1999. Ms. Jacobs retired from Theragenics Corporation, a manufacturer of prostate cancer treatment devices and surgical products, in 2013, having served as its Chairman, President and Chief Executive Officer. She held the position of Chairman from 2007 to 2013, and previously from 1998 to 2005. She was Co-Chairman of the Board from 1997 to 1998 and was elected President in 1992 and Chief Executive Officer in 1993. Ms. Jacobs has been a director of the Company since January 1999. She is a member of the Compensation Committee and the Governance Committee. Having led a public company within the healthcare industry for over 20 years, Ms. Jacobs brings to our Board significant relevant industry experience and a keen understanding of and strong insight into issues, challenges and opportunities facing the Company, including those related to legislative healthcare initiatives. As a Chairman and Chief Executive Officer of Theragenics Corporation, she was at the forefront of her company in regard to the evolving corporate governance environment, which enables her to provide ongoing valuable contributions as a member of the Governance Committee of our Board. In September 2011, Ms. Jacobs began serving as Co-Chair of the Securities and Exchange Commission (“SEC”) Advisory Committee on Small and Emerging Companies, which reflects her leadership and public company experience, including capital formation experience. At the request of SEC Chair Mary Jo White, she served a second term in that role. Ms. Jacobs’ Co-Chair term ended September 2015.

Donald Knauss

Mr. Donald R. Knauss is Independent Director of Mckesson Corporation. Mr. Knauss retired from The Clorox Company in 2015, having served as Executive Chairman of the Board from November 2014 until July 2015 and Chairman and Chief Executive Officer from October 2006 until November 2014. He was Executive Vice President of The Coca-Cola Company and President and Chief Operating Officer for Coca-Cola North America from February 2004 until September 2006. Prior to his employment with The Coca-Cola Company, he held various positions in marketing and sales with PepsiCo, Inc. and Procter & Gamble and served as an officer in the United States Marine Corps. He is also a director of the Kellogg Company and Target Corporation. He was formerly a director of URS Corporation. Mr. Knauss has been a director of the Company since October 2014. He is a member of the Audit Committee and the Governance Committee. Mr. Knauss has gained substantial Board leadership skills through his chairmanship role at The Clorox Company. He also brings substantial executive experience, including in the roles of Chief Executive Officer, President and Chief Operating Officer, through which he has developed valuable operational insights and strategic and long-term planning capabilities. In addition, Mr. Knauss possesses extensive international business management experience, which provides him with valuable insights into global business strategy. He also possesses extensive retail expertise, which includes experience in the retail pharmacy area. Mr. Knauss also has significant other public company board experience. Having worked outside of the healthcare industry, and as a new member of the Company’s Board, Mr. Knauss enhances the diverse perspectives on the Board.

Marie Knowles

Ms. Marie L. Knowles is an Independent Director of McKesson Corporation. Ms. Knowles retired from Atlantic Richfield Company (“ARCO”) in 2000 and was Executive Vice President and Chief Financial Officer from 1996 until 2000. She joined ARCO in 1972 and held a number financial and operating management positions including President of ARCO Transportation Company from 1993 to 1996. Ms. Knowles is also the Chair of the Independent Trustees Fidelity Fixed Income and Asset Allocation Funds. Ms. Knowles was formerly a director of America West Holdings Corporation, ARCO, Phelps Dodge Corporation and URS Corporation. She has been a director of the Company since March 2002. She is Chair of the Audit Committee and a member of the Finance Committee. Ms. Knowles brings to the Board extensive financial experience gained through her career at ARCO, including her tenure as Chief Financial Officer. This experience makes her well qualified to serve as Chair of the Company’s Audit Committee and as the audit committee financial expert. This experience also enables Ms. Knowles to provide critical insight into, among other things, the Company’s financial statements, accounting principles and practices, internal control over financial reporting, and risk management processes. It is also noteworthy that Ms. Knowles was named a 2013 Outstanding Director by the San Francisco Business Times and the Silicon Valley Business Journal.

Susan Salka

Ms. Susan R. Salka is an Independent Director of McKesson Corporation. Ms. Salka has served as Chief Executive Officer and President of AMN Healthcare Services, Inc. since 2005, and a director of the company since 2003. She has served in several other executive roles since joining the company in 1990, including Chief Operating Officer, Chief Financial Officer and Senior Vice President of Business Development. She was formerly a director of Beckman Coulter Inc. and Playtex Products. Ms. Salka has been a director of the Company since October 2014. She is a member of the Audit Committee and the Governance Committee. With over 25 years of experience in the healthcare services industry, Ms. Salka brings to the Board a deep understanding of emerging trends in healthcare services. This industry experience gives her insight into important aspects of the Company’s businesses, including opportunities potentially available to those businesses. She has also served in a number of executive leadership positions, including as a Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, which have provided her with business management, operational, financial and long-range planning experience. Ms. Salka also brings valuable experience acquired through significant public company board service. In addition, she brings a fresh perspective, having joined the Board in October 2014.

Erin Lampert

Basic Compensation